Mackie Research analyst Nikhil Thadani says the share price for theScore (theScore Stock Quote, Chart TSXV:SCR) should benefit from the company’s … [Read more...] about theScore has an 89 per cent upside, Mackie Research says
About Jayson MacLean
Viemed Healthcare’s stock is worth a look, Kim Bolton says
So far, small-cap Viemed Healthcare (Viemed Healthcare Stock Quote, Chart TSX:VMD) has done extremely well over its short life as a public company, … [Read more...] about Viemed Healthcare’s stock is worth a look, Kim Bolton says
Electronic Arts is getting killed by mobile gaming, this investor says
Last year, Electronic Arts (Electronic Arts Stock Quote, Chart NASDAQ:EA) and other gaming stocks got smashed by the Fortnite juggernaut which … [Read more...] about Electronic Arts is getting killed by mobile gaming, this investor says
Beat down Boeing is a buy, this fund manager says
Investors may be wondering how long Boeing's (Boeing Stock Quote, Chart NYSE:BA) current troubles will weigh on its share price, but while it’s … [Read more...] about Beat down Boeing is a buy, this fund manager says
Antibe Therapeutics has an upside of 352 per cent, Echelon Wealth says
In an update to clients Wednesday, Echelon Wealth Partners analyst Douglas Loe remains bullish on clinical stage drug developer Antibe Therapeutics … [Read more...] about Antibe Therapeutics has an upside of 352 per cent, Echelon Wealth says
Telus is a strong defensive investment, this portfolio manager says
Is Telus (Telus Stock Quote, Chart TSX:T) the right defensive play among Canada’s telcos? Possibly, says Norman Levine of Portfolio Management, … [Read more...] about Telus is a strong defensive investment, this portfolio manager says
Paradigm Capital launches coverage of Organigram with a Buy
Calling the company’s cultivation techniques paradigm-shifting and its operational efficiencies industry-leading, Paradigm Capital’s Rahul Sarugaser … [Read more...] about Paradigm Capital launches coverage of Organigram with a Buy
Horizons Marijuana Life Sciences Index ETF is a buy, says this portfolio manager
Looking to invest in the cannabis space? Mike Philbrick, president of ReSolve Asset Management, says that since it’s still too early to pick the … [Read more...] about Horizons Marijuana Life Sciences Index ETF is a buy, says this portfolio manager
Canopy Rivers has a huge upside, says PI Financial
Devin Schilling of PI Financial is bullish on cannabis investment platform Canopy Rivers (Canopy Rivers Stock Quote, Chart TSXV:RIV), who just jumped … [Read more...] about Canopy Rivers has a huge upside, says PI Financial
ProMetic Life Sciences is not out of the woods yet, Echelon Wealth says
Echelon Wealth Partners analyst Douglas Loe says ProMetic Life Sciences (ProMetic Life Sciences Stock Quote, Chart TSX:PLI) is not out of the woods … [Read more...] about ProMetic Life Sciences is not out of the woods yet, Echelon Wealth says
